Immuron Ltd Files October 2025 6-K Report
Ticker: IMRN · Form: 6-K · Filed: Oct 27, 2025 · CIK: 1660046
| Field | Detail |
|---|---|
| Company | Immuron LTD (IMRN) |
| Form Type | 6-K |
| Filed Date | Oct 27, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, foreign-private-issuer, regulatory-update
Related Tickers: IMRN
TL;DR
Immuron Ltd (IMRN) filed its October 6-K, confirming 20-F filing status. No major news, just routine reporting.
AI Summary
Immuron Limited filed a Form 6-K on October 27, 2025, reporting its activities for the month of October 2025. The filing indicates that the company is a foreign private issuer and will file its annual reports under Form 20-F. The report does not contain specific financial figures or operational updates beyond the filing type and period.
Why It Matters
This filing serves as an update for investors regarding Immuron Ltd's regulatory reporting status as a foreign private issuer. It confirms their adherence to SEC filing requirements.
Risk Assessment
Risk Level: low — This filing is a routine report of foreign private issuer activities and does not contain significant new financial or operational information that would immediately impact risk.
Key Players & Entities
- Immuron Limited (company) — Registrant
- 001-38104 (other) — SEC File Number
- Form 20-F (document) — Annual Report Filing Type
- October 2025 (date) — Reporting Period
FAQ
What is the purpose of this Form 6-K filing for Immuron Limited?
The Form 6-K is a Report of Foreign Private Issuer filed by Immuron Limited for the month of October 2025, to report information that it has made or is required to make public in Australia or that it has filed or will file with the SEC.
Does Immuron Limited file annual reports under Form 20-F or Form 40-F?
Immuron Limited indicates it files annual reports under cover of Form 20-F.
Is Immuron Limited furnishing information under Rule 12g3-2(b)?
No, Immuron Limited is not furnishing information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
What is the principal executive office address for Immuron Limited?
The principal executive office address for Immuron Limited is Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
What is the filing date and reporting period for this 6-K?
This Form 6-K was filed on October 27, 2025, and it reports for the month of October 2025.
Filing Stats: 311 words · 1 min read · ~1 pages · Grade level 18.7 · Accepted 2025-10-27 06:51:03
Filing Documents
- ea0262575-6k_immuron.htm (6-K) — 13KB
- ea026257501ex99-1_immuron.htm (EX-99.1) — 32KB
- ex99-1_001.jpg (GRAPHIC) — 3KB
- 0001213900-25-102342.txt ( ) — 50KB
From the Filing
OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of October 2025 Commission File Number: 001-38104 IMMURON LIMITED (Name of Registrant) Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes No If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- IMMURON LIMITED EXPLANATORY NOTE Immuron Limited (the “Company”) published one announcement (the “Public Notices”) to the Australian Securities Exchange on October 27, 2025 titled: - - Notification of cessation of securities A copy of the Public Notice is attached as an exhibit to this report on Form 6-K. This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. 1 EXHIBITS Exhibit Number Description 99.1 Notification of cessation of securities 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMURON LIMITED Date: October 27, 2025 By: /s/ Phillip Hains Phillip Hains Company Secretary 3